Please login to the form below

Not currently logged in
Email:
Password:

Teva appoints UK & Ireland general manager

Promotes UK chief operating officer Kim Innes

Teva Kim InnesTeva UK has promoted chief operating officer Kim Innes to general manager of its UK and Ireland business, succeeding Richard Daniell.

Innes brings almost 25 years of industry experience to the role, during which time she served a two-year term as chair of the British Generic Manufacturers' Association.

She became head of Teva's generics business unit in the UK in 2006, before taking on her most recent position as chief operating officer in which she played a key role in the company's acquisition of Actavis Generics.

Innes said: “I am excited to be leading this great organisation at what is a transformational time for both Teva as a company and the pharmaceutical industry as a whole.

“We have an extremely talented group of people here in the UK and Ireland and I am confident that we will continue to maintain our leadership position while keeping an absolute focus on our patients and customers.”

10th October 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics